{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:57:23Z","timestamp":1793141843287,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019562","name":"Synoptik Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ophtha.2025.07.027","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:43:38Z","timestamp":1753919018000},"page":"1393-1401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival Outcomes of Uveal Melanoma Involving the Anterior Chamber of the Eye"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-8611","authenticated-orcid":false,"given":"Kristoffer","family":"Nissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid-Helene","family":"Ravn J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3619-413X","authenticated-orcid":false,"given":"Susanne","family":"Rosth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Gadegaard","family":"Hindso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2517-7270","authenticated-orcid":false,"given":"Carsten","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Bagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5906-7670","authenticated-orcid":false,"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-1460","authenticated-orcid":false,"given":"Jens Folke","family":"Kiilgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2025.07.027_bib1","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1111\/aos.14847","article-title":"Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort","volume":"99","author":"Smidt-Nielsen","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09286580591000836","article-title":"Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study","volume":"12","author":"Isager","year":"2005","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","article-title":"Incidence of uveal melanoma in the United States: 1973-1997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib4","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","article-title":"Incidence of uveal melanoma in Europe","volume":"114","author":"Virgili","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.survophthal.2023.05.006","article-title":"Iris melanoma: prognostication for metastasis","volume":"68","author":"Melendez-Moreno","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ophtha.2017.11.040","article-title":"Iris melanoma outcomes based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 patients","volume":"125","author":"Shields","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib7","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.ophtha.2018.03.047","article-title":"Long-term metastatic risk after biopsy of posterior uveal melanoma","volume":"125","author":"Bagger","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib8","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.07.027_bib9","series-title":"AJCC Cancer Staging Manual","first-page":"816","author":"Amin","year":"2017"},{"key":"10.1016\/j.ophtha.2025.07.027_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.1964.00970010641006","article-title":"Ring melanoma","volume":"71","author":"Manschot","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/112067219300300402","article-title":"Malignant melanoma of the iris. A 25-year analysis of Danish cases","volume":"3","author":"Jensen","year":"1993","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamaophthalmol.2014.5395","article-title":"International validation of the American Joint Committee on Cancer\u2019s 7th edition classification of uveal melanoma","volume":"133","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1167\/iovs.16-20212","article-title":"The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status","volume":"58","author":"Dogrus\u00f6z","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.07.027_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1167\/iovs.14-15571","article-title":"The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma","volume":"56","author":"Bagger","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.07.027_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.13858","article-title":"Intraocular biopsy of uveal melanoma risk assessment and identification of genetic prognostic markers","volume":"96","author":"Bagger","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib16","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1002\/sim.5903","article-title":"Decomposition of number of life years lost according to causes of death","volume":"32","author":"Andersen","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2025.07.027_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jnci\/djx179","article-title":"Understanding and communicating measures of treatment effect on survival: can we do better?","volume":"110","author":"Saad","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2025.07.027_bib19","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archopht.1997.01100160707007","article-title":"Factors predictive of growth and treatment of small choroidal melanoma: COMS report no. 5","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9394(98)00039-7","article-title":"The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10","volume":"125","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.85.6.666","article-title":"Factors associated with elevated intraocular pressure in eyes with iris melanoma","volume":"85","author":"Shields","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.2005.088294","article-title":"Iris ring melanoma: fine needle biopsy","volume":"90","author":"Char","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5114\/jcb.2021.108598","article-title":"Brachytherapy or enucleation in ring melanoma patients: which is better? Preliminary results of the authors\u2019 own experiences","volume":"13","author":"Markiewicz","year":"2021","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.ophtha.2025.07.027_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ophtha.2010.09.018","article-title":"Iris melanoma risk factors for metastasis in 169 consecutive patients","volume":"118","author":"Hood","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0039-6257(85)90207-3","article-title":"Iris melanoma. Nevus or malignancy?","volume":"29","author":"Kersten","year":"1985","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib28","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/archopht.1981.03930020993002","article-title":"Are most iris \u201cmelanomas\u2019\u2019 really nevi? A clinicopathologic study of 189 lesions","volume":"99","author":"Jakobiec","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib29","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/bjo-2023-324558","article-title":"Predictive model for iris melanoma","volume":"108","author":"Singh","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2025.07.027_bib30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ophtha.2017.12.022","article-title":"Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential","volume":"125","author":"van Poppelen","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib31","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1167\/iovs.17-21838","article-title":"Frequent GNAQ, GNA11, and EIF1AX mutations in iris melanoma","volume":"58","author":"Scholz","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2025.07.027_bib32","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bjophthalmol-2015-308301","article-title":"Genetic findings in treatment-na\u00efve and proton-beam-radiated iris melanomas","volume":"100","author":"Krishna","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2025.07.027_bib33","doi-asserted-by":"crossref","first-page":"213.e1","DOI":"10.1016\/j.ophtha.2012.08.016","article-title":"Gene expressing profiling of iris melanomas","volume":"120","author":"Harbour","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2025.07.027_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16276-8","article-title":"Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours","volume":"11","author":"Johansson","year":"2020","journal-title":"Nat Commun"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025004610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642025004610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:29:01Z","timestamp":1771417741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642025004610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0161642025004610"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.07.027","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Outcomes of Uveal Melanoma Involving the Anterior Chamber of the Eye","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2025.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}